Long Reads, Better Answers, Rare Diagnoses: Clinical Long-Read Sequencing Enters Prime Time 🧬🔍📈

🧬 Exciting advances in rare disease diagnostics!   A new NEJM report shows that long-read genome sequencing (lrGS) can function as a first-tier diagnostic test, achieving a higher diagnostic yield than standard approaches (19.2% vs. 16.5%) and an impressive 96.4% concordance. 🚀   Beyond identifying conventional variants, lrGS improves haplotype phasing, detects novel variants, and provides epigenetic insights through DNA methylation analysis. In a modeled real-world cohort of 15,150 patients, lrGS increased diagnostic yield by 2.5 percentage points.   A glimpse into the future of precision medicine and rare disease care. 🧬🔍📈 #Genomics #RareDisease #PrecisionMedicine #MedicalPodcasts #NEJM